Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2007
03/29/2007WO2007034986A1 Gene encoding cell wall mannoprotein and use thereof
03/29/2007WO2007034984A1 Gene encoding cell wall mannoprotein and use of the same
03/29/2007WO2007034977A1 METHOD OF ESTIMATING AND IDENTIFYING TARGET mRNA CONTROLLED BY FUNCTIONAL RNA AND METHOD OF USING THE SAME
03/29/2007WO2007034953A1 Protoporphyrinogen oxidase having activity of imparting resistance against acifluorfen and gene thereof
03/29/2007WO2007034897A1 Method for determination of the length of g-tail sequence and kit for the method
03/29/2007WO2007034809A1 Host cell for producing recombinant protein
03/29/2007WO2007034782A1 Recombinant vector capable of increasing secretion of koji mold protease
03/29/2007WO2007034753A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient
03/29/2007WO2007034693A1 Novel endoribonuclease
03/29/2007WO2007034649A1 Transgenic pig with diabetes and method for producing the same
03/29/2007WO2007034603A1 Marker gene for malignant brain tumor and use thereof
03/29/2007WO2007034581A1 Plasmid for lactic acid bacteria
03/29/2007WO2007034527A2 snRNA GENE-LIKE TRANSCRIPTIONAL UNITS AND USES THEREOF
03/29/2007WO2007034507A2 Tetravalent dengue specific domain iii based chimeric recombinant protein
03/29/2007WO2007034487A1 Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
03/29/2007WO2007034262A1 Heterodimeric meganucleases and use thereof
03/29/2007WO2007034169A2 Cell selection and reporter system
03/29/2007WO2007033587A1 A method for isolating a bi-directional gene promotor and the use thereof
03/29/2007WO2007033529A1 A gene encoding antibacterial protein of fenneropenaeus chinensis and its recombination expression method and uses
03/29/2007WO2007033475A1 THE USE OF siRNAs IN ORGAN STORAGE/REPERFUSION SOLUTIONS
03/29/2007WO2007033436A1 Modulation of gene expression and agents useful for same
03/29/2007WO2007033424A1 Compositions and methods for transfecting cells
03/29/2007WO2007014844A3 Selection system for maize transformation
03/29/2007WO2007013807A3 Targeting-enhanced activation of galectins
03/29/2007WO2007012614A3 Novel anti-igf-ir antibodies and uses thereof
03/29/2007WO2007011221A3 Anti fungal screening method
03/29/2007WO2007002088A3 Psat1s as modifiers of the pten/akt pathway and methods of use
03/29/2007WO2006138527A3 Genes of an otitis media isolate of nontypeable haemophilus influenzae
03/29/2007WO2006134496A3 Homeologous recombination in msh2 inactivated plants or cells thereof
03/29/2007WO2006133356A3 Elimination of n-glycolylneuraminic acid from mammalian products for human use
03/29/2007WO2006130716A3 Method of inhibiting intimal hyperplasia
03/29/2007WO2006128100A3 Chondrogenic compositions and methods of use
03/29/2007WO2006128084A3 Trps1-mediated modulation of hair growth
03/29/2007WO2006126030A3 Malaria vaccines
03/29/2007WO2006121664A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
03/29/2007WO2006111745A3 Composition and method for treating viral infection
03/29/2007WO2006111387A3 Mammalian expression vector comprising the mcmv promoter and first intron of hcmv major immediate early gene
03/29/2007WO2006110508A3 Plants with increased phosphorous uptake
03/29/2007WO2006110506A3 Root-specific phoshate transporter promoters
03/29/2007WO2006106336A3 Rat primers
03/29/2007WO2006106331A3 Mouse primers
03/29/2007WO2006105339A3 Gene synthesis using pooled dna
03/29/2007WO2006100679A3 Recombinant antibodies against human type ii transglutaminase and uses thereof
03/29/2007WO2006096130A8 Arabinose- and xylose-fermenting saccharomyces cerevisiae strains
03/29/2007WO2006088490A3 Oligonucleotides comprising a non-phosphate backbone linkage
03/29/2007WO2006086454A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
03/29/2007WO2006084005A3 Emergence of a r-type ca2+channel(cav2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage
03/29/2007WO2006076683A3 Isolation and detection of pathogenic prions
03/29/2007WO2006066224A3 Virulence targeted antibiotics
03/29/2007WO2006008653A3 Lipolytic enzyme uses thereof in the food industry
03/29/2007WO2005053811A3 Biomolecule partition motifs and uses thereof
03/29/2007WO2005053505A8 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis
03/29/2007WO2005035730A3 Dna sequences of the botulinum neurotoxin complex of type a-hall (allergan) strain
03/29/2007WO2004081197A3 Immune response associated proteins
03/29/2007WO2004043399A3 Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines
03/29/2007US20070074314 Vectors and methods for improved plant transformation efficiency
03/29/2007US20070074313 Native antibiotic resistance genes
03/29/2007US20070074312 Plants containing a heterologous flavohemoglobin gene and methods of use thereof
03/29/2007US20070074311 Compositions and methods for modulating expression of gene products
03/29/2007US20070074310 Plants synthesizing a modified starch, a process for the generation of the plants, their use, and the modified starch
03/29/2007US20070074309 Polypeptides and expression vectors host cell and transgenic plants with nucleic acid and stress resistance; antifungal agent
03/29/2007US20070074308 Useful in protecting plants from insect damage; also included are micro-organisms and plants transformed with DNA sequence encoding an insecticidal Cry1Bf protein to obtain a plant resistant to insects
03/29/2007US20070074307 Citrus tristeza virus resistance genes and methods of use
03/29/2007US20070074306 Plant transcriptional activator and uses thereof
03/29/2007US20070074305 nucleic acid molecule comprising a first nucleic acid segment encoding a polypeptide, and a second nucleic acid segment for suppression of a polypeptide involved in altering oleic acid content in a plant cell
03/29/2007US20070074304 Low acrylamide foods
03/29/2007US20070074303 Methods and compositions for controlling weeds
03/29/2007US20070074302 Triticale cultivar 97TV38011
03/29/2007US20070074299 Transgenic Mice Containing GPCR5-1 Gene Disruptions
03/29/2007US20070074295 Schizophrenia related gene
03/29/2007US20070073048 Hiv polynucleotides and polypeptides derived from botswana mj4
03/29/2007US20070073043 Process for producing humanized chimera antibody
03/29/2007US20070073042 Novel MHC II associated peptides
03/29/2007US20070073041 Human tumor necrosis factor receptor polypeptides
03/29/2007US20070073040 Anti-obesity polypeptides
03/29/2007US20070072841 Therapeutic compounds
03/29/2007US20070072823 siRNA targeting survivin
03/29/2007US20070072820 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
03/29/2007US20070072819 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
03/29/2007US20070072818 Endothelial growth factors; antiischemic agents; neovascularization
03/29/2007US20070072816 Methods for inhibiting angiogenesis
03/29/2007US20070072815 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
03/29/2007US20070072807 Method of screening compounds
03/29/2007US20070072805 Fusion peptide-induced hemolysis effectively inhibited by peptides of the invention compared to virus-inhibitory peptide (VIRIP); peptide blocks cellular infection by HIV particles by interacting with the fusion peptide of HIV viral glycoprotein 41 (gp41) to prevent virus entry into thecell
03/29/2007US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2
03/29/2007US20070072796 Oligonucleotide analogues incorporating 5-aza-cytosine therein
03/29/2007US20070072794 Novel genes and proteins encoded thereby
03/29/2007US20070072297 Method for ligating nucleic acids and molecular cloning
03/29/2007US20070072296 C/EBPalpha gene targeting constructs and uses thereof
03/29/2007US20070072282 Bovine adeno-associated viral (baav) vector and uses thereof
03/29/2007US20070072280 Materials and methods for the efficient production of xylitol
03/29/2007US20070072279 Evolved micro-organisms for the production of 1,2-propanediol
03/29/2007US20070072278 Reductase gene and use thereof
03/29/2007US20070072275 Method for breeding lipid-producing fungus
03/29/2007US20070072274 Nucleic acids, expression vectors, host cells, and improved exogenous gene expression in microorganisms; amino acid biosynthesis of fine chemicals
03/29/2007US20070072273 use in host cells for biosynthesis of fine chemicals such as lysine; gene stability, gene expression or protein secretion/protein folding (SES proteins)
03/29/2007US20070072272 Industrial method for producing rna and system for carrying out said method
03/29/2007US20070072270 PS4 variant with a proline substitution, derivable from a parent polypeptide, having non-maltogenic exoamylase activity; higher thermostability compared to the parent polypeptide
03/29/2007US20070072269 Ubiquitin-specific protease occurring in the brain and DNA encoding the same
03/29/2007US20070072268 Sulfotransferase and DNA encoding the enzyme
1 ... 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 ... 4023